Physical Isolation Strategy in Multi-Layer Self-Nanoemulsifying Pellets: Improving Dissolution and Drug Loading Efficiency of Ramipril

Abstract
Background and Purpose
Highlights
- Innovative Approach: The study successfully developed multi-layer self-nanoemulsifying pellets (ML-SNEP) to address stability, handling, and storage challenges in liquid SNEDDS, particularly for lipophilic and unstable drugs like ramipril (RMP) and thymoquinone (THQ).
- Enhanced Stability and Dissolution: ML-SNEP demonstrated significant improvements in the stability and dissolution of RMP and THQ, with over 86% release within 60 minutes in in vitro studies.
- Optimized Manufacturing Process: The fluid bed coating process was meticulously optimized, achieving high coating recovery (>80%) and excellent mono-pellet percentages (≥97%).
- Superior Drug Loading Efficiency: The physical isolation strategy in ML-SNEP led to a substantial increase in RMP loading efficiency, reaching 109%, compared to 55% in single-layer SNEP.
- Comprehensive Characterization: The pellets were thoroughly characterized using SEM, DSC, XRD, and in vitro dissolution studies, confirming well-defined layers, RMP amorphization, and high dissolution efficiency.
- No Negative Impact from Functional Layers: The addition of moisture sealing and anti-adherent layers did not negatively affect drug release, with SNEP-5L showing enhanced dissolution efficiency for both RMP and THQ.
Methods
Results
Conclusion
This study successfully developed and optimized ML-SNEP as a novel approach for enhancing the stability and release of RMP and THQ. The physical isolation strategy was a key approach in enhancing drug loading efficiency while preserving the advantageous dissolution properties of liquid SNEDDS. This approach offers valuable insights for developing advanced oral drug delivery systems for poorly water-soluble and labile drugs
Read more here
Materials
The materials utilized in this study encompassed a diverse range of compounds sourced from reputable suppliers worldwide. Bioactive Oil (BSO) was extracted through the cold press method, as outlined in our prior work23, from raw seeds. Ramipril (RMP), serving as the model drug, was procured from Jai Radhe Sales (Ahmedabad, India), while thymoquinone (THQ) was obtained from Sigma-Aldrich (St. Louis, MO, USA). Emulsifiers and surfactants, including Imwitor 988 (I988), Imwitor 308 (I308)
Ahmad Abdul-Wahhab Shahba, Abdelrahman Y. Sherif, Ehab M. Elzayat, Shaukat Ali, Mohsin Kazi, Physical Isolation Strategy in Multi-Layer Self-Nanoemulsifying Pellets: Improving Dissolution and Drug Loading Efficiency of Ramipril, Journal of Pharmaceutical Sciences, 2025, ISSN 0022-3549, https://doi.org/10.1016/j.xphs.2025.01.017.
Visit our Excipient Landscape 2024 here:
Get more information on different excipients and their manufacturers
